Around 12–20% of invasive breast cancers have a HER2 gene amplification, which generally results in overexpression of the HER2 protein (Kraus et al., 1987; Ross, 2010; Venter et al., 1987). Here, ERBB2 is linked to invasive breast carcinoma.